2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine
C51H29N3O2S — CID 160836791
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine
2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine (PubChem CID 160836791) has the molecular formula C51H29N3O2S and a molecular weight of 747.88 g/mol. Its IUPAC name is 2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine |
|---|---|
| PubChem CID | 160836791 |
| Molecular Formula | C51H29N3O2S |
| Molecular Weight | 747.88 g/mol |
| Exact Mass | 747.20 |
| IUPAC Name | 2-[9-(6-dibenzofuran-2-yldibenzothiophen-4-yl)dibenzofuran-4-yl]-4,6-diphenyl-1,3,5-triazine |
| SMILES | c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3oc3cccc(-c5cccc6c5sc5c(-c7ccc8oc9ccccc9c8c7)cccc56)c34)n2)cc1 |
| InChI | InChI=1S/C51H29N3O2S/c1-3-13-30(14-4-1)49-52-50(31-15-5-2-6-16-31)54-51(53-49)40-24-11-23-39-45-35(19-12-26-44(45)56-46(39)40)36-20-10-22-38-37-21-9-18-33(47(37)57-48(36)38)32-27-28-43-41(29-32)34-17-7-8-25-42(34)55-43/h1-29H |
| InChIKey | WNNIMOWSTARKOM-UHFFFAOYSA-N |
| XLogP | 14.37 |
| TPSA | 64.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 747.88 |
| LogP ≤ 5 | 14.37 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160836791 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.